{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:46:05Z","timestamp":1793191565159,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T00:00:00Z","timestamp":1524528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Bubble Foundation UK"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0807-5","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T07:21:53Z","timestamp":1524554513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":181,"title":["Adenosine deaminase deficiency: a review"],"prefix":"10.1186","volume":"13","author":[{"given":"Aisling M.","family":"Flinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Gennery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,24]]},"reference":[{"issue":"2","key":"807_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.iac.2010.01.002","volume":"30","author":"HB Gaspar","year":"2010","unstructured":"Gaspar HB. Bone marrow transplantation and alternatives for adenosine deaminase deficiency. Immunol Allergy Clin N Am. 2010;30(2):221\u201336.","journal-title":"Immunol Allergy Clin N Am"},{"key":"807_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fimmu.2012.00265","volume":"3","author":"A Sauer","year":"2012","unstructured":"Sauer A, Brigida I, Carriglio N, Aiuti A. Autoimmune Dysregulation and Purine metabolism in adenosine deaminase deficiency. Front Immunol. 2012;3:265.","journal-title":"Front Immunol"},{"issue":"5120","key":"807_CR3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1126\/science.8101391","volume":"261","author":"J Kameoka","year":"1993","unstructured":"Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C. Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science. 1993;261(5120):466\u20139.","journal-title":"Science"},{"issue":"2","key":"807_CR4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4049\/jimmunol.155.2.536","volume":"155","author":"P Benveniste","year":"1995","unstructured":"Benveniste P, Zhu W, Cohen A. Interference with thymocyte differentiation by an inhibitor of S-adenosylhomocysteine hydrolase. J Immunol. 1995;155(2):536\u201344.","journal-title":"J Immunol"},{"key":"807_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2776(04)86001-2","volume":"86","author":"MR Blackburn","year":"2005","unstructured":"Blackburn MR, Kellems RE. Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation. Adv Immunol. 2005;86:1\u201341.","journal-title":"Adv Immunol"},{"key":"807_CR6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1146\/annurev.immunol.22.012703.104731","volume":"22","author":"MV Sitkovsky","year":"2004","unstructured":"Sitkovsky MV, Lukashev D, Apasov S, et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol. 2004;22:657\u201382.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"807_CR7","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3390\/ijms15022024","volume":"15","author":"S Sheth","year":"2014","unstructured":"Sheth S, Brito R, Mukherjea D, Rybak LP, Ramkumar V. Adenosine receptors: expression, function and regulation. Int J Mol Sci. 2014;15(2):2024\u201352.","journal-title":"Int J Mol Sci"},{"key":"807_CR8","volume-title":"GeneReviews(R)","author":"M Hershfield","year":"1993","unstructured":"Hershfield M. Adenosine Deaminase Deficiency. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews(R). Seattle (WA): University of Washington, Seattle, University of Washington, Seattle: GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved; 1993."},{"issue":"4","key":"807_CR9","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1086\/302054","volume":"63","author":"FX Arredondo-Vega","year":"1998","unstructured":"Arredondo-Vega FX, Santisteban I, Daniels S, Toutain S, Hershfield MS. Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles. Am J Hum Genet. 1998;63(4):1049\u201359.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"807_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0090-1229(78)90100-9","volume":"9","author":"R Hirschhorn","year":"1978","unstructured":"Hirschhorn R, Martiniuk F, Rosen FS. Adenosine deaminase activity in normal tissues and tissues from a child with severe combined immunodeficiency and adenosine deaminase deficiency. Clin Immunol Immunopathol. 1978;9(3):287\u201392.","journal-title":"Clin Immunol Immunopathol"},{"issue":"1","key":"807_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1172\/JCI200110360","volume":"108","author":"SG Apasov","year":"2001","unstructured":"Apasov SG, Blackburn MR, Kellems RE, Smith PT, Sitkovsky MV. Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling. J Clin Invest. 2001;108(1):131\u201341.","journal-title":"J Clin Invest"},{"issue":"10","key":"807_CR12","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.4049\/jimmunol.171.10.5562","volume":"171","author":"MB Aldrich","year":"2003","unstructured":"Aldrich MB, Chen W, Blackburn MR, Martinez-Valdez H, Datta SK, Kellems RE. Impaired germinal center maturation in adenosine deaminase deficiency. J Immunol. 2003;171(10):5562\u201370.","journal-title":"J Immunol"},{"issue":"6","key":"807_CR13","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1172\/JCI4320","volume":"103","author":"L Gangi-Peterson","year":"1999","unstructured":"Gangi-Peterson L, Sorscher DH, Reynolds JW, Kepler TB, Mitchell BS. Nucleotide pool imbalance and adenosine deaminase deficiency induce alterations of N-region insertions during V(D)J recombination. J Clin Invest. 1999;103(6):833\u201341.","journal-title":"J Clin Invest"},{"issue":"1","key":"807_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1067\/mpd.2001.115023","volume":"139","author":"MH Rogers","year":"2001","unstructured":"Rogers MH, Lwin R, Fairbanks L, Gerritsen B, Gaspar HB. Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency. J Pediatr. 2001;139(1):44\u201350.","journal-title":"J Pediatr"},{"issue":"9","key":"807_CR15","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1182\/blood-2008-04-151332","volume":"112","author":"P Titman","year":"2008","unstructured":"Titman P, Pink E, Skucek E, et al. Cognitive and behavioral abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficiencies. Blood. 2008;112(9):3907\u201313.","journal-title":"Blood"},{"issue":"4","key":"807_CR16","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/0387-7604(96)00014-9","volume":"18","author":"C Tanaka","year":"1996","unstructured":"Tanaka C, Hara T, Suzaki I, Maegaki Y, Takeshita K. Sensorineural deafness in siblings with adenosine deaminase deficiency. Brain and Development. 1996;18(4):304\u20136.","journal-title":"Brain and Development"},{"issue":"2","key":"807_CR17","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jpeds.2003.10.055","volume":"144","author":"W Albuquerque","year":"2004","unstructured":"Albuquerque W, Gaspar HB. Bilateral sensorineural deafness in adenosine deaminase-deficient severe combined immunodeficiency. J Pediatr. 2004;144(2):278\u201380.","journal-title":"J Pediatr"},{"issue":"3","key":"807_CR18","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.4049\/jimmunol.175.3.1937","volume":"175","author":"JL Chunn","year":"2005","unstructured":"Chunn JL, Molina JG, Mi T, Xia Y, Kellems RE, Blackburn MR. Adenosine-dependent pulmonary fibrosis in adenosine deaminase-deficient mice. J Immunol. 2005;175(3):1937\u201346.","journal-title":"J Immunol"},{"issue":"3","key":"807_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10875-012-9658-3","volume":"32","author":"C Booth","year":"2012","unstructured":"Booth C, Algar VE, Xu-Bayford J, Fairbanks L, Owens C, Gaspar HB. Non-infectious lung disease in patients with adenosine deaminase deficient severe combined immunodeficiency. J Clin Immunol. 2012;32(3):449\u201353.","journal-title":"J Clin Immunol"},{"issue":"6","key":"807_CR20","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.jaci.2012.02.003","volume":"129","author":"E Grunebaum","year":"2012","unstructured":"Grunebaum E, Cutz E, Roifman CM. Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency. J Allergy Clin Immunol. 2012;129(6):1588\u201393.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"807_CR21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00247-012-2564-2","volume":"43","author":"D Manson","year":"2013","unstructured":"Manson D, Diamond L, Oudjhane K, Hussain FB, Roifman C, Grunebaum E. Characteristic scapular and rib changes on chest radiographs of children with ADA-deficiency SCIDS in the first year of life. Pediatr Radiol. 2013;43(5):589\u201392.","journal-title":"Pediatr Radiol"},{"issue":"1","key":"807_CR22","first-page":"157","volume":"120","author":"H Ratech","year":"1985","unstructured":"Ratech H, Greco MA, Gallo G, Rimoin DL, Kamino H, Hirschhorn R. Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations. Am J Pathol. 1985;120(1):157\u201369.","journal-title":"Am J Pathol"},{"issue":"15","key":"807_CR23","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1182\/blood-2009-03-209221","volume":"114","author":"AV Sauer","year":"2009","unstructured":"Sauer AV, Mrak E, Hernandez RJ, et al. ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL\/OPG imbalance and osteoblast insufficiency. Blood. 2009;114(15):3216\u201326.","journal-title":"Blood"},{"issue":"6","key":"807_CR24","first-page":"115","volume":"12","author":"I Kaitila","year":"1976","unstructured":"Kaitila I, Rimoin DL, Cedarbaum SD, Stiehm ER, Lachman RS. Chondroosseous histopathology in adenosine deaminase deficient combined immunodeficiency disease. Birth Defects Orig Artic Ser. 1976;12(6):115\u201321.","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"9","key":"807_CR25","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1073\/pnas.92.9.3673","volume":"92","author":"M Wakamiya","year":"1995","unstructured":"Wakamiya M, Blackburn MR, Jurecic R, et al. Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice. Proc Natl Acad Sci U S A. 1995;92(9):3673\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"807_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1055\/s-0030-1269916","volume":"223","author":"JS Kuhl","year":"2011","unstructured":"Kuhl JS, Schwarz K, Munch A, et al. Hyperbilirubinemia and rapid fatal hepatic failure in severe combined immunodeficiency caused by adenosine deaminase deficiency (ADA-SCID). Klin Padiatr. 2011;223(2):85\u20139.","journal-title":"Klin Padiatr"},{"issue":"21","key":"807_CR27","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1056\/NEJM199605233342104","volume":"334","author":"ME Bollinger","year":"1996","unstructured":"Bollinger ME, Arredondo-Vega FX, Santisteban I, Schwarz K, Hershfield MS, Lederman HM. Brief report: Hepatic dysfunction as a complication of adenosine deaminase deficiency. N Engl J Med. 1996;334(21):1367\u201371.","journal-title":"N Engl J Med"},{"issue":"4","key":"807_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s10875-015-0158-0","volume":"35","author":"O Nikolajeva","year":"2015","unstructured":"Nikolajeva O, Worth A, Hague R, et al. Adenosine deaminase deficient severe combined immunodeficiency presenting as atypical haemolytic uraemic syndrome. J Clin Immunol. 2015;35(4):366\u201372.","journal-title":"J Clin Immunol"},{"issue":"3","key":"807_CR29","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jaci.2011.10.028","volume":"129","author":"C Kesserwan","year":"2012","unstructured":"Kesserwan C, Sokolic R, Cowen EW, et al. Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency. J Allergy Clin Immunol. 2012;129(3):762\u2013769.e761.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"807_CR30","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1172\/JCI116833","volume":"92","author":"I Santisteban","year":"1993","unstructured":"Santisteban I, Arredondo-Vega FX, Kelly S, et al. Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late\/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype. J Clin Invest. 1993;92(5):2291\u2013302.","journal-title":"J Clin Invest"},{"issue":"8858","key":"807_CR31","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/0140-6736(93)90910-9","volume":"341","author":"CL Shovlin","year":"1993","unstructured":"Shovlin CL, Hughes JM, Simmonds HA, et al. Adult presentation of adenosine deaminase deficiency. Lancet. 1993;341(8858):1471.","journal-title":"Lancet"},{"issue":"8","key":"807_CR32","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00431-009-1131-9","volume":"169","author":"H Artac","year":"2010","unstructured":"Artac H, Gokturk B, Bozdemir SE, et al. Late-onset adenosine deaminase deficiency presenting with Heck's disease. Eur J Pediatr. 2010;169(8):1033\u20136.","journal-title":"Eur J Pediatr"},{"issue":"6","key":"807_CR33","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1172\/JCI110944","volume":"71","author":"R Hirschhorn","year":"1983","unstructured":"Hirschhorn R, Martiniuk F, Roegner-Maniscalco V, Ellenbogen A, Perignon JL, Jenkins T. Genetic heterogeneity in partial adenosine deaminase deficiency. J Clin Invest. 1983;71(6):1887\u201392.","journal-title":"J Clin Invest"},{"issue":"1","key":"807_CR34","first-page":"13","volume":"38","author":"R Hirschhorn","year":"1986","unstructured":"Hirschhorn R, Ellenbogen A. Genetic heterogeneity in adenosine deaminase (ADA) deficiency: five different mutations in five new patients with partial ADA deficiency. Am J Hum Genet. 1986;38(1):13\u201325.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"807_CR35","first-page":"820","volume":"54","author":"FX Arredondo-Vega","year":"1994","unstructured":"Arredondo-Vega FX, Santisteban I, Kelly S, Schlossman CM, Umetsu DT, Hershfield MS. Correct splicing despite mutation of the invariant first nucleotide of a 5\u2032 splice site: a possible basis for disparate clinical phenotypes in siblings with adenosine deaminase deficiency. Am J Hum Genet. 1994;54(5):820\u201330.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"807_CR36","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/S0022-3476(76)80792-5","volume":"89","author":"T Jenkins","year":"1976","unstructured":"Jenkins T, Rabson AR, Nurse GT, Lane AB. Deficiency of adenosine deaminase not associated with severe combined immunodeficiency. J Pediatr. 1976;89(5):732\u20136.","journal-title":"J Pediatr"},{"issue":"3","key":"807_CR37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF00282554","volume":"74","author":"SL Hart","year":"1986","unstructured":"Hart SL, Lane AB, Jenkins T. Partial adenosine deaminase deficiency: another family from southern Africa. Hum Genet. 1986;74(3):307\u201312.","journal-title":"Hum Genet"},{"issue":"2","key":"807_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.clim.2005.07.006","volume":"117","author":"B Chan","year":"2005","unstructured":"Chan B, Wara D, Bastian J, et al. Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID). Clin Immunol. 2005;117(2):133\u201343.","journal-title":"Clin Immunol"},{"issue":"4","key":"807_CR39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s10875-017-0373-y","volume":"37","author":"DB Kohn","year":"2017","unstructured":"Kohn DB, Gaspar HB. How we manage adenosine deaminase-deficient severe combined immune deficiency (ADA SCID). J Clin Immunol. 2017;37(4):351\u20136.","journal-title":"J Clin Immunol"},{"issue":"17","key":"807_CR40","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1182\/blood-2011-12-396879","volume":"120","author":"A Hassan","year":"2012","unstructured":"Hassan A, Booth C, Brightwell A, et al. Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency. Blood. 2012;120(17):3615\u201324. quiz 3626","journal-title":"Blood"},{"issue":"5235","key":"807_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1126\/science.270.5235.475","volume":"270","author":"RM Blaese","year":"1995","unstructured":"Blaese RM, Culver KW, Miller AD, et al. T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science. 1995;270(5235):475\u201380.","journal-title":"Science"},{"issue":"5235","key":"807_CR42","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1126\/science.270.5235.470","volume":"270","author":"C Bordignon","year":"1995","unstructured":"Bordignon C, Notarangelo LD, Nobili N, et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients. Science. 1995;270(5235):470\u20135.","journal-title":"Science"},{"issue":"4999","key":"807_CR43","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1126\/science.1848369","volume":"251","author":"G Ferrari","year":"1991","unstructured":"Ferrari G, Rossini S, Giavazzi R, et al. An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency. Science. 1991;251(4999):1363\u20136.","journal-title":"Science"},{"issue":"1","key":"807_CR44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1182\/blood-2016-01-688226","volume":"128","author":"MP Cicalese","year":"2016","unstructured":"Cicalese MP, Ferrua F, Castagnaro L, et al. Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency. Blood. 2016;128(1):45\u201354.","journal-title":"Blood"},{"issue":"6","key":"807_CR45","doi-asserted-by":"publisher","first-page":"737","DOI":"10.15252\/emmm.201707573","volume":"9","author":"A Aiuti","year":"2017","unstructured":"Aiuti A, Roncarolo MG, Naldini L. Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products. EMBO Mol Med. 2017;9(6):737\u201340.","journal-title":"EMBO Mol Med"},{"issue":"5577","key":"807_CR46","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1126\/science.1070104","volume":"296","author":"A Aiuti","year":"2002","unstructured":"Aiuti A, Slavin S, Aker M, et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science. 2002;296(5577):2410\u20133.","journal-title":"Science"},{"issue":"5","key":"807_CR47","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1056\/NEJMoa0805817","volume":"360","author":"A Aiuti","year":"2009","unstructured":"Aiuti A, Cattaneo F, Galimberti S, et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med. 2009;360(5):447\u201358.","journal-title":"N Engl J Med"},{"issue":"5","key":"807_CR48","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1172\/JCI90367","volume":"127","author":"KL Shaw","year":"2017","unstructured":"Shaw KL, Garabedian E, Mishra S, et al. Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency. J Clin Invest. 2017;127(5):1689\u201399.","journal-title":"J Clin Invest"},{"issue":"4","key":"807_CR49","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nm1393","volume":"12","author":"MG Ott","year":"2006","unstructured":"Ott MG, Schmidt M, Schwarzwaelder K, et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med. 2006;12(4):401\u20139.","journal-title":"Nat Med"},{"issue":"227","key":"807_CR50","doi-asserted-by":"publisher","first-page":"227ra233","DOI":"10.1126\/scitranslmed.3007280","volume":"6","author":"CJ Braun","year":"2014","unstructured":"Braun CJ, Boztug K, Paruzynski A, et al. Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity. Sci Transl Med. 2014;6(227):227ra233.","journal-title":"Sci Transl Med"},{"issue":"9","key":"807_CR51","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1172\/JCI35700","volume":"118","author":"S Hacein-Bey-Abina","year":"2008","unstructured":"Hacein-Bey-Abina S, Garrigue A, Wang GP, et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest. 2008;118(9):3132\u201342.","journal-title":"J Clin Invest"},{"issue":"3","key":"807_CR52","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/mt.2013.265","volume":"22","author":"DA Carbonaro","year":"2014","unstructured":"Carbonaro DA, Zhang L, Jin X, et al. Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency. Mol Ther. 2014;22(3):607\u201322.","journal-title":"Mol Ther"},{"issue":"Supplement 1","key":"807_CR53","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1016\/S1525-0016(16)33866-7","volume":"23","author":"HB Gaspar","year":"2015","unstructured":"Gaspar HB, Buckland K, Carbonaro DA, et al. C-8. Immunological and metabolic correction after lentiviral vector gene therapy for ADA deficiency. Mol Ther. 2015;23(Supplement 1):S102\u20133.","journal-title":"Mol Ther"},{"key":"807_CR54","unstructured":"New Horizons in the Management of ADA-SCID. http:\/\/www.ada-scid.online\/editorial\/new-emerging-therapies\/: Springer Healthcare IME."},{"issue":"3","key":"807_CR55","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10875-014-0007-6","volume":"34","author":"SP Adams","year":"2014","unstructured":"Adams SP, Rashid S, Premachandra T, et al. Screening of neonatal UK dried blood spots using a duplex TREC screening assay. J Clin Immunol. 2014;34(3):323\u201330.","journal-title":"J Clin Immunol"},{"issue":"11","key":"807_CR56","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1182\/blood-2010-08-300384","volume":"117","author":"L Brown","year":"2011","unstructured":"Brown L, Xu-Bayford J, Allwood Z, et al. Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening. Blood. 2011;117(11):3243\u20136.","journal-title":"Blood"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0807-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0807-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0807-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T03:52:03Z","timestamp":1693626723000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0807-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,24]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["807"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0807-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,24]]},"assertion":[{"value":"23 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"65"}}